EMERGENT BIOSOLUTIONS INC. (EBS) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $100.00K; Additional Paid in CapitalUSD $951.80M; Treasury Stock, Common, ValueUSD $270.50M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $100.00K; Additional Paid in CapitalUSD $944.50M; Treasury Stock, Common, ValueUSD $261.60M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $100.00K; Additional Paid in CapitalUSD $942.40M; Treasury Stock, Common, ValueUSD $252.60M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $100.00K; Additional Paid in CapitalUSD $938.60M; Treasury Stock, Common, ValueUSD $243.50M.
EMERGENT BIOSOLUTIONS INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Treasury Stock, Common, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Treasury Stock, Common, Shares shares | Treasury Stock, Value, Acquired, Cost Method USD | Treasury Stock, Shares, Acquired shares | Treasury Stock Acquired, Average Cost Per Share USD/shares | Treasury Stock, Value USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Treasury Stock, Value, Acquired, Par Value Method USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $100.00K | $951.80M | $270.50M | $-6.80M | $-333.20M | $341.40M | 10.70M | 3 month · $8.90M | 3 month · 1.10M 6 month · 1.90M | 3 month · 8.38 6 month · 9.21 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $100.00K | $944.50M | $261.60M | $-6.90M | $-153.00M | $523.10M | 9.60M | 3 month · $9.00M | 3 month · 900.00K | 3 month · 10.21 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $100.00K | $942.40M | $252.60M | $-7.50M | $-159.80M | $522.60M | 8.70M | 12 month · $24.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $100.00K | $938.60M | $243.50M | $-7.50M | $-105.20M | $582.50M | 7.90M | 3 month · $8.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $100.00K | $935.20M | $234.60M | $-8.10M | $-156.40M | $536.20M | 6.70M | 3 month · $6.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $100.00K | $930.80M | $227.70M | $-6.10M | $-144.40M | $552.70M | 5.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $100.00K | $928.00M | $227.70M | $-5.20M | $-212.40M | $482.80M | 5.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $100.00K | $924.40M | $227.70M | $-7.30M | $-181.10M | $508.40M | 5.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $100.00K | $915.30M | $227.70M | $-5.50M | $-295.90M | $386.30M | 5.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $100.00K | $909.80M | $227.70M | $-5.50M | $-12.80M | $663.90M | 5.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $100.00K | $904.40M | $227.70M | $-5.70M | $-21.80M | $649.30M | 5.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $100.00K | $899.70M | $227.70M | $-2.60M | $27.70M | $697.20M | 5.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $100.00K | $895.80M | (m) | $-1.60M | $289.70M | $957.70M | 5.60M | (m) | (m) | (m) | $227.70M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $100.00K | $878.20M | (m) | $1.00M | $551.00M | $1.20B | 5.60M | (m) | (m) | (m) | $227.70M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $100.00K | $873.50M | $227.70M | $3.10M | $738.70M | $1.39B | 5.60M | (m) | (m) | 12 month · 42.36 | $227.70M | (m) | (m) | (m) | (m) | (m) | 5.60M |
| 2022-09-30 | $0.00 | $100.00K | $860.10M | $227.70M | $-5.20M | $805.70M | $1.43B | 5.60M | (m) | (m) | (m) | $227.70M | (m) | (m) | (m) | (m) | (m) | 5.60M |
| 2022-06-30 | $0.00 | $100.00K | $849.20M | (m) | $-6.10M | $897.70M | $1.51B | (m) | (m) | (m) | (m) | $227.70M | (m) | (m) | (m) | (m) | (m) | 5.60M |
| 2022-03-31 | $0.00 | $100.00K | $834.80M | (m) | $-9.30M | $954.10M | $1.57B | (m) | (m) | (m) | (m) | $204.40M | (m) | (m) | (m) | (m) | (m) | 4.90M |
| 2021-12-31 | $0.00 | $100.00K | $829.40M | (m) | $-16.10M | $950.30M | $1.61B | (m) | (m) | (m) | 12 month · 42.67 | $152.20M | (m) | (m) | (m) | (m) | (m) | 3.80M |
| 2021-09-30 | $0.00 | $100.00K | $816.80M | (m) | $-23.10M | $768.50M | $1.52B | (m) | (m) | (m) | (m) | $39.60M | (m) | (m) | (m) | (m) | (m) | 1.20M |
| 2021-06-30 | $0.00 | $100.00K | $804.40M | (m) | $-22.40M | $801.20M | $1.54B | (m) | (m) | (m) | (m) | $39.60M | (m) | (m) | (m) | (m) | (m) | 1.20M |
| 2021-03-31 | $0.00 | $100.00K | $790.10M | (m) | $-24.40M | $796.60M | $1.52B | (m) | (m) | (m) | (m) | $39.60M | (m) | (m) | (m) | (m) | (m) | 1.20M |
| 2020-12-31 | $0.00 | $100.00K | $784.90M | (m) | $-25.30M | $726.90M | $1.45B | (m) | (m) | (m) | (m) | $39.60M | (m) | (m) | (m) | 12 month · $-3.90M | (m) | 1.20M |
| 2020-09-30 | $0.00 | $100.00K | $770.90M | (m) | $-21.40M | $541.50M | $1.25B | (m) | (m) | (m) | (m) | $39.60M | (m) | (m) | (m) | (m) | (m) | 1.20M |
| 2020-06-30 | $0.00 | $100.00K | $758.50M | (m) | $-22.20M | $502.00M | $1.20B | (m) | (m) | (m) | (m) | $39.60M | (m) | (m) | (m) | (m) | (m) | 1.20M |
| 2020-03-31 | $0.00 | $100.00K | $726.20M | (m) | $-21.20M | $409.30M | $1.07B | (m) | (m) | (m) | (m) | $39.60M | (m) | (m) | (m) | (m) | (m) | 1.20M |
| 2019-12-31 | $0.00 | $100.00K | $716.10M | (m) | $-9.90M | $421.80M | $1.09B | (m) | (m) | (m) | (m) | $39.60M | (m) | (m) | (m) | 12 month · $-600.00K | (m) | 1.20M |
| 2019-09-30 | $0.00 | $100.00K | $708.80M | (m) | $-9.10M | $374.90M | $1.03B | (m) | (m) | (m) | (m) | $39.70M | (m) | (m) | (m) | (m) | (m) | 1.20M |
| 2019-06-30 | $0.00 | $100.00K | $701.80M | (m) | $-5.00M | $331.70M | $988.90M | (m) | (m) | (m) | (m) | $39.70M | (m) | (m) | (m) | (m) | (m) | 1.20M |
| 2019-03-31 | $0.00 | $100.00K | $690.20M | (m) | $-4.50M | $341.30M | $987.30M | (m) | (m) | (m) | (m) | $39.60M | $987.50M | (m) | (m) | (m) | (m) | 1.20M |
| 2018-12-31 | $0.00 | $100.00K | $688.60M | (m) | $-5.50M | $367.30M | $1.01B | (m) | (m) | (m) | (m) | $39.60M | $1.01B | 12 month · $100.00K | (m) | (m) | (m) | 1.20M |
| 2018-09-30 | $0.00 | $51.00K | $640.18M | (m) | $-4.67M | $370.73M | $966.60M | (m) | (m) | (m) | (m) | $39.64M | $966.65M | (m) | (m) | (m) | (m) | 1.22M |
| 2018-06-30 | $0.00 | $51.00K | $632.57M | (m) | $-4.42M | $349.78M | $938.40M | (m) | (m) | (m) | (m) | $39.64M | $938.35M | (m) | (m) | (m) | (m) | 1.22M |
| 2018-03-31 | $0.00 | $50.00K | $624.48M | (m) | $-3.25M | $299.64M | $881.30M | (m) | (m) | (m) | (m) | $39.64M | $881.30M | (m) | (m) | (m) | (m) | 1.22M |
| 2017-12-31 | $0.00 | $100.00K | $618.30M | (m) | $-3.70M | $337.10M | $912.30M | (m) | (m) | (m) | (m) | $39.50M | $912.30M | 12 month · $33.10M | (m) | (m) | (m) | 1.20M |
| 2017-09-30 | $0.00 | $41.00K | $370.86M | (m) | $-3.81M | $303.13M | (m) | (m) | (m) | (m) | (m) | $6.50M | $663.71M | (m) | (m) | (m) | (m) | 425.55K |
| 2017-06-30 | $0.00 | $41.00K | $361.00M | (m) | $-3.52M | $269.58M | (m) | (m) | (m) | (m) | (m) | $6.50M | $620.60M | (m) | (m) | (m) | (m) | 425.55K |
| 2017-03-31 | $0.00 | $41.00K | $355.66M | (m) | $-3.75M | $264.96M | (m) | (m) | (m) | (m) | (m) | $6.50M | $610.42M | (m) | (m) | (m) | (m) | 425.49K |
| 2016-12-31 | $0.00 | $41.00K | $352.44M | (m) | $-4.33M | $254.48M | $596.20M | (m) | (m) | (m) | (m) | $6.42M | $596.20M | 12 month · $0.00 | (m) | (m) | (m) | 422.83K |
| 2016-09-30 | $0.00 | $41.00K | $342.89M | (m) | $-3.57M | $214.69M | (m) | (m) | (m) | (m) | (m) | $6.42M | $547.62M | (m) | (m) | (m) | (m) | 422.83K |
| 2016-06-30 | $0.00 | $41.00K | $337.95M | (m) | $-3.08M | $344.18M | (m) | (m) | (m) | (m) | (m) | $6.42M | $672.67M | (m) | (m) | (m) | (m) | 422.83K |
| 2016-03-31 | $0.00 | $40.00K | $322.38M | (m) | $-4.15M | $355.13M | (m) | (m) | (m) | (m) | (m) | $6.42M | $666.98M | (m) | (m) | (m) | (m) | 422.83K |
| 2015-12-31 | $0.00 | $40.00K | $317.97M | (m) | $-2.71M | $351.14M | (m) | (m) | (m) | (m) | (m) | $6.42M | $660.00M | (m) | (m) | (m) | (m) | 422.83K |
| 2015-09-30 | $0.00 | $39.00K | $297.95M | (m) | $-4.15M | $317.79M | (m) | (m) | (m) | (m) | (m) | $6.32M | $605.31M | (m) | (m) | (m) | (m) | 420.19K |
| 2015-06-30 | $0.00 | $39.00K | $291.34M | (m) | $-3.66M | $280.85M | (m) | (m) | (m) | (m) | (m) | $6.32M | $562.25M | (m) | (m) | (m) | (m) | 420.19K |
| 2015-03-31 | $0.00 | $38.00K | $280.65M | (m) | $-3.24M | $266.75M | (m) | (m) | (m) | (m) | (m) | $6.32M | $537.88M | (m) | (m) | (m) | (m) | 420.19K |
| 2014-12-31 | $0.00 | $38.00K | $274.22M | (m) | $-3.01M | $288.27M | $553.20M | (m) | (m) | (m) | (m) | $6.32M | $553.20M | (m) | (m) | (m) | (m) | 420.19K |
| 2014-09-30 | $0.00 | $38.00K | $264.88M | (m) | $-3.81M | $258.15M | $513.14M | (m) | (m) | (m) | (m) | $6.12M | $513.14M | (m) | (m) | (m) | (m) | 412.95K |
| 2014-06-30 | $0.00 | $38.00K | $260.78M | (m) | $-3.25M | $236.32M | $487.77M | (m) | (m) | (m) | (m) | $6.12M | $487.77M | (m) | (m) | (m) | (m) | 412.95K |
| 2014-03-31 | $0.00 | $38.00K | $255.68M | (m) | $-3.39M | $231.29M | $477.50M | (m) | (m) | (m) | (m) | $6.12M | $477.50M | (m) | (m) | (m) | (m) | 412.95K |
| 2013-12-31 | $0.00 | $37.00K | $247.64M | (m) | $-3.46M | $251.53M | $489.62M | (m) | (m) | (m) | (m) | $6.12M | $489.17M | (m) | (m) | (m) | (m) | 412.95K |
| 2013-09-30 | $0.00 | $37.00K | $240.37M | (m) | $-3.50M | $236.31M | $467.31M | (m) | (m) | (m) | (m) | $5.91M | $466.86M | (m) | (m) | (m) | (m) | 403.16K |
| 2013-06-30 | $0.00 | $36.00K | $236.10M | (m) | $-3.51M | $222.81M | $449.53M | (m) | (m) | (m) | (m) | $5.91M | $449.08M | (m) | (m) | (m) | (m) | 403.16K |
| 2013-03-31 | $0.00 | $36.00K | $232.89M | (m) | $-3.76M | $212.33M | $435.59M | (m) | (m) | (m) | (m) | $5.91M | $435.81M | (m) | (m) | (m) | (m) | 403.16K |
| 2012-12-31 | $0.00 | $36.00K | $230.96M | (m) | $-4.13M | $220.39M | $441.36M | (m) | (m) | (m) | (m) | $5.91M | $442.13M | (m) | (m) | (m) | (m) | 403.16K |
| 2012-09-30 | $0.00 | $36.00K | $228.08M | (m) | $-3.90M | $204.29M | $427.04M | (m) | (m) | (m) | (m) | $1.46M | $428.41M | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | $0.00 | $36.00K | $225.23M | (m) | $-3.25M | $197.67M | $419.69M | (m) | (m) | (m) | (m) | (m) | $422.52M | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | $0.00 | $36.00K | $222.75M | (m) | $-3.23M | $190.04M | $409.59M | (m) | (m) | (m) | (m) | (m) | $412.10M | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $0.00 | $36.00K | $220.65M | (m) | $-3.31M | $196.87M | $414.25M | (m) | (m) | (m) | (m) | $0.00 | $416.73M | (m) | 12 month · $10.74M | (m) | 12 month · $2.20M | 0.00 |
| 2011-09-30 | $0.00 | $36.00K | $215.94M | (m) | $-2.89M | $168.21M | $381.29M | (m) | (m) | (m) | (m) | (m) | $384.50M | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $0.00 | $36.00K | $213.32M | (m) | $-2.77M | $166.66M | $377.25M | (m) | (m) | (m) | (m) | (m) | $381.23M | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $0.00 | $35.00K | $197.69M | (m) | $-2.11M | $173.85M | $369.46M | (m) | (m) | (m) | (m) | (m) | $373.56M | (m) | 12 month · $7.06M | (m) | 12 month · $1.70M | (m) |
| 2009-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $243.81M | (m) | 12 month · $5.01M | (m) | 12 month · $1.85M | (m) |
| 2008-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $199.35M | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |